Bromelain, a potential therapeutic compound from ananas comosus
Lokman Hekim Health Sciences · 2021
DOI: 10.14744/lhhs.2021.10001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lokman Hekim Health Sciences, 2021. Verfasst von Aydın Alper Şahin. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Bromelain is a mixture of enzymes found in crude extract from the fruit and other parts of the pineapple Ananas comosus (Linn.), Bromeliaceae family. Bromelain is a nontoxic compound having various industrial and therapeutic applications. It consists of varied closely related proteinases that are important as anti-inflammatory, antithrombotic, and fibrinolytic agents. Bromelain is widely administered for its well-known properties, such as anticancer activity, antioxidant activity, and immunomodulatory effects. It also plays a major role in the modulation of the immune system and prevents the harmful effects of the cytokine storm. Because of all these therapeutic effects, bromelain appears to be a potential candidate to inhibit and prevent the symptoms of different diseases as well being an effective, natural, therapeutic weapon for the treatment of severe COVID-19 infection.
Zitieren
APA
Şahin, A. A. (2021). Bromelain, a potential therapeutic compound from ananas comosus. Lokman Hekim Health Sciences. https://doi.org/10.14744/lhhs.2021.10001
Vancouver
Şahin AA. Bromelain, a potential therapeutic compound from ananas comosus. Lokman Hekim Health Sciences. 2021. doi:10.14744/lhhs.2021.10001
BibTeX
@article{ahin2021,
author = {Şahin, Aydın Alper},
title = {Bromelain, a potential therapeutic compound from ananas comosus},
journal = {Lokman Hekim Health Sciences},
year = {2021},
doi = {10.14744/lhhs.2021.10001}
}
EUVIMED